Litcius/Paper detail

Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV

Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi

2023Seminars in Thrombosis and Hemostasis18 citationsDOIOpen Access PDF

Abstract

Welcome to another issue of Seminars in Thrombosis and Hemostasis (STH), published under the "banner" of "Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)," this being Part IV, or the fourth such volume. The first three issues were, respectively, published in 2020,[1] 2021,[2] and 2022,[3] and proved very popular with the STH readership. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Believed to originate from Wuhan City in China, with the first reported case in November 2019, at the time of writing, there were over 630 million cases reported worldwide and over 6.5 million attributable deaths, thus including it among the 10 most deadly pandemics throughout recent human history.[4]

Topics & Concepts

HemostasisPandemicMedicineThrombosisCoronavirus disease 2019 (COVID-19)CoronavirusDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineVirologyOutbreakInternal medicineInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsVenous Thromboembolism Diagnosis and Management